Subintimal excimer laser coronary atherectomy (S-ELCA) as a bail-out for device-uncrossable chronic total occlusion:

Ahmed Elsherif1, Ameenathul Fawzy1, Sophia Khattak1,2

  • 1Department of Interventional Cardiology, Queen Elizabeth Hospital, Birmingham, University Hospital Birmingham NHS Trust, Mindelsohn Way, Birmingham B15 2GW, UK.

Insights

Subintimal excimer laser coronary angioplasty (SELCA) offers a safe solution for device-uncrossable chronic total occlusions (CTOs) during percutaneous coronary intervention. This technique facilitated vascular healing at the laser site, demonstrating long-term safety in complex CTO cases.

Area of Science:

  • Cardiovascular Medicine
  • Interventional Cardiology
  • Medical Devices

Background:

  • Chronic total occlusions (CTOs) pose significant challenges in percutaneous coronary intervention (PCI), especially when devices cannot cross lesions.
  • Excimer laser coronary angioplasty (ELCA) is used for device-uncrossable lesions, but its safety in the subintimal space is not well-established.
Abstract

Related Concept Videos